Telix Pharmaceuticals (TLX) Other Gross PP&E Adjustments (2023 - 2024)
Telix Pharmaceuticals has reported Other Gross PP&E Adjustments over the past 2 years, most recently at $31.4 million for Q4 2024.
- Quarterly Other Gross PP&E Adjustments rose 91.98% to $31.4 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $31.4 million through Dec 2024, up 91.98% year-over-year, with the annual reading at $31.4 million for FY2024, 91.98% up from the prior year.
- Other Gross PP&E Adjustments was $31.4 million for Q4 2024 at Telix Pharmaceuticals, up from $16.4 million in the prior quarter.
- Over five years, Other Gross PP&E Adjustments peaked at $31.4 million in Q4 2024 and troughed at $16.4 million in Q4 2023.